Literature DB >> 18653200

Age and apoE associations with complex pathologic features in Alzheimer's disease.

Gregory A Jicha1, Joseph E Parisi, Dennis W Dickson, Ruth H Cha, Kris A Johnson, Glenn E Smith, Bradley F Boeve, Ronald C Petersen, David S Knopman.   

Abstract

The risk for Alzheimer's disease (AD) is influenced by both age and ApoE status. The present study addresses the associations of age and ApoE status on complex pathologic features in AD (n=81) including coexistent cerebrovascular disease (CVD), argyrophilic grain disease (AGD), and Lewy body disease (LBD). The frequency of coexistent cerebrovascular disease increased with increasing age. Age and ApoE status were differentially associated with atherosclerosis, lacunar infarctions, and microvascular pathology. Coexistent Lewy body pathology was negatively associated with age, dropping off abruptly after age 90. The presence of an ApoE epsilon4 allele was associated with an increased frequency of coexistent LBD. Logistic regression analyses demonstrated both dependent and independent effects of age and ApoE status on the presence of coexistent Lewy body pathology in AD. While the decreasing frequency of LBD in AD after age 90 could be partly accounted for by a lower probability of an ApoE epsilon4 allele, the independent association with age suggests either 1) a survival effect, 2) decreased incidence with advancing age, or 3) both.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18653200      PMCID: PMC2569823          DOI: 10.1016/j.jns.2008.06.008

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  64 in total

1.  Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study.

Authors:  H Petrovitch; L R White; G W Ross; S C Steinhorn; C Y Li; K H Masaki; D G Davis; J Nelson; J Hardman; J D Curb; P L Blanchette; L J Launer; K Yano; W R Markesbery
Journal:  Neurology       Date:  2001-07-24       Impact factor: 9.910

2.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

Review 3.  Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease.

Authors:  J C Morris; J L Price
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

4.  The importance of cerebral lesions of vascular origin in the morphopathologic picture of old age dementia.

Authors:  M Alexianu; B Tudorache; M Podani
Journal:  Neurol Psychiatr (Bucur)       Date:  1989 Apr-Jun

5.  Postmortem MRI and histopathology of white matter changes in Alzheimer brains. A quantitative, comparative study.

Authors:  Lena Bronge; Nenad Bogdanovic; Lars-Olof Wahlund
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

6.  Incidence of stroke in relation to cognitive function and dementia in the Kungsholmen Project.

Authors:  L Zhu; L Fratiglioni; Z Guo; B Winblad; M Viitanen
Journal:  Neurology       Date:  2000-06-13       Impact factor: 9.910

7.  The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity.

Authors:  L Hansen; D Salmon; D Galasko; E Masliah; R Katzman; R DeTeresa; L Thal; M M Pay; R Hofstetter; M Klauber
Journal:  Neurology       Date:  1990-01       Impact factor: 9.910

Review 8.  Dementia epidemiology.

Authors:  Walter A Kukull; James D Bowen
Journal:  Med Clin North Am       Date:  2002-05       Impact factor: 5.456

Review 9.  Mixed dementia: epidemiology, diagnosis, and treatment.

Authors:  Dina Zekry; Jean-Jacques Hauw; Gabriel Gold
Journal:  J Am Geriatr Soc       Date:  2002-08       Impact factor: 5.562

10.  Argyrophilic grain disease is a sporadic 4-repeat tauopathy.

Authors:  Takashi Togo; Naruhiko Sahara; Shu-Hui Yen; Natalie Cookson; Takashi Ishizawa; Mike Hutton; Rohan de Silva; Andrew Lees; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2002-06       Impact factor: 3.685

View more
  11 in total

Review 1.  Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies.

Authors:  Peter T Nelson; Elizabeth Head; Frederick A Schmitt; Paulina R Davis; Janna H Neltner; Gregory A Jicha; Erin L Abner; Charles D Smith; Linda J Van Eldik; Richard J Kryscio; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-04-24       Impact factor: 17.088

2.  Substantia nigra depigmentation and exposure to encephalitis lethargica.

Authors:  Nawaz Hack; Gregory A Jicha; Annalisa Abell; Dawson Dean; Jerrold L Vitek; Joseph R Berger
Journal:  Ann Neurol       Date:  2012-12       Impact factor: 10.422

3.  Antemortem Prediction of Braak Stage.

Authors:  Jesper O E Carlson; Margaret Gatz; Nancy L Pedersen; Caroline Graff; Inger Nennesmo; Anna-Karin Lindström; Lotte Gerritsen
Journal:  J Neuropathol Exp Neurol       Date:  2015-11       Impact factor: 3.685

4.  Neuropathologic features associated with Alzheimer disease diagnosis: age matters.

Authors:  L E Middleton; L T Grinberg; B Miller; C Kawas; K Yaffe
Journal:  Neurology       Date:  2011-10-26       Impact factor: 9.910

5.  Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART).

Authors:  Keith A Josephs; Melissa E Murray; Nirubol Tosakulwong; Jennifer L Whitwell; David S Knopman; Mary M Machulda; Stephen D Weigand; Bradley F Boeve; Kejal Kantarci; Leonard Petrucelli; Val J Lowe; Clifford R Jack; Ronald C Petersen; Joseph E Parisi; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2017-02-03       Impact factor: 17.088

6.  Preclinical AD Workgroup staging: pathological correlates and potential challenges.

Authors:  Gregory A Jicha; Erin L Abner; Frederick A Schmitt; Richard J Kryscio; Kathryn P Riley; Gregory E Cooper; Nancy Stiles; Marta S Mendiondo; Charles D Smith; Linda J Van Eldik; Peter T Nelson
Journal:  Neurobiol Aging       Date:  2011-04-19       Impact factor: 4.673

7.  Brain pathologies in extreme old age.

Authors:  Janna H Neltner; Erin L Abner; Gregory A Jicha; Frederick A Schmitt; Ela Patel; Leonard W Poon; Gearing Marla; Robert C Green; Adam Davey; Mary Ann Johnson; S Michal Jazwinski; Sangkyu Kim; Daron Davis; John L Woodard; Richard J Kryscio; Linda J Van Eldik; Peter T Nelson
Journal:  Neurobiol Aging       Date:  2015-10-19       Impact factor: 4.673

Review 8.  Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease.

Authors:  Gregory A Jicha; Sarah A Carr
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

9.  Apolipoprotein E Proteinopathy Is a Major Dementia-Associated Pathologic Biomarker in Individuals with or without the APOE Epsilon 4 Allele.

Authors:  Jozsef Gal; Yuriko Katsumata; Haining Zhu; Sukanya Srinivasan; Jing Chen; Lance Allen Johnson; Wang-Xia Wang; Lesley Renee Golden; Donna M Wilcock; Gregory A Jicha; Matthew D Cykowski; Peter Tobias Nelson
Journal:  Am J Pathol       Date:  2021-12-24       Impact factor: 4.307

10.  The occurrence of cerebrovascular atherosclerosis in Alzheimer's disease patients.

Authors:  Jing Yuan; Ge Wen; Yingjia Li; Changxing Liu
Journal:  Clin Interv Aging       Date:  2013-05-24       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.